A leader in the development of novel diagnostic and therapeutic applications for virology, genomics and oncology, KSL Biomedical, recently announced that it has acquired Toronto-based Pulse Scientific.
The acquisition plots further expansion into Canada for U.S.-based KSL Biomedical, according to Business Wire.
"Our leadership team brings to Canada decades of scientific training and experience in diagnostics and deep relationships with market leaders who can assist in identifying emerging industry opportunities and introducing novel applications to address them," President and CEO of KSL Biomedical Kevin Lawson said. "We expect the acquisition to invigorate access to markets for existing Pulse Scientific and KSL Biomedical products, as well as complementary products to be identified by our incoming Canadian business development team."
The Pulse Scientific acquisition paves the way for KSL to add proprietary products and services into its line of services.
According to Business Wire, KSL Biomedical Canada is now looking to add staff as part of an expansion.
"It is an exciting opportunity for Pulse Scientific to be part of a vibrant and forward-thinking organization like KSL," President of Pulse Scientific, Allen Chan said. "The clear business vision and strategy planning, coupled with strong business ethics among the principals, will bring (continued) success to their corporation. I personally will be able to contribute in sales and marketing efforts with rewarding experiences."